Subclinical atherosclerosis in young Thai adults with juvenile-onset systemic lupus erythematosus

被引:0
|
作者
Pattrakornkul, Nalinee [1 ]
Pruangprasert, Patamakom [1 ]
Chanthong, Prakul [1 ]
Chawanasuntorapoj, Ratana [2 ]
Pattaragarn, Anirut [1 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Dept Pediat, Fac Med, Bangkok 10700, Thailand
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Med, Bangkok 10700, Thailand
关键词
Atherosclerosis; carotid intima-media thickness; juvenile-onset systemic lupus erythematosus; subclinical atherosclerosis; systemic lupus erythematosus; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; CYCLOSPORINE-A; BLOOD-PRESSURE; PROGRESSION; ALBUMINURIA; NEPHRITIS; UPDATE;
D O I
10.5372/1905-7415.1002.475
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in adult patients with systemic lupus erythematosus (SLE). Increased risk of CVD and atherosclerosis has been demonstrated in children with SLE. However, evidence of atherosclerosis in adults with juvenile-onset SLE is limited and their additional CVD risk factors unclear. Objectives: To investigate the presence of subclinical atherosclerosis in young Thai adults with juvenile-onset SLE, and evaluate atherosclerotic risk factors. Methods: We recruited a cohort of patients aged 18-40 years who had been diagnosed SLE before the age of 18 years for this observational study. Patients with chronic kidney disease stage IV or V, alcoholism, chronic liver disease, or life threatening illness were excluded. Common carotid intima-media thickness (CCIMT) was measured. Clinical and laboratory parameters, treatment, and SLE-related factors, which could be risk factors for atherosclerosis and classic risk factors were obtained. Results: We enrolled 29 patients (24 female). Their mean age was 25.1 years and mean disease duration 11.3 years. The age of participants, persistent proteinuria and use of cyclosporin correlated with increased CCIMT by multivariable analysis (P = 0.02, 0.02, and 0.03, respectively). These patients had significantly abnormal CCIMT when compared with a healthy population (mean 690 (SD 150) mu m versus mean 447 (SD 76) mu m, respectively; P < 0.001). Conclusions: Subclinical atherosclerosis, identified by abnormal CCIMT, appears in young adults with juvenile-onset SLE. The CCIMT abnormality progresses with increasing age, and persistent proteinuria and use of cyclosporin appears to increase the risk for atherosclerosis.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 50 条
  • [21] The Role of Neutrophil Apoptosis in Juvenile-Onset Systemic Lupus Erythematosus
    Midgley, Angela
    McLaren, Zoe
    Moots, Robert J.
    Edwards, Steven W.
    Beresford, Michael W.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (08): : 2390 - 2401
  • [22] Juvenile-onset systemic lupus erythematosus in Malay children Reply
    Hamid, Wan Zuraida W. A.
    SAUDI MEDICAL JOURNAL, 2018, 39 (08) : 846 - 847
  • [23] Ocular Manifestations in Children with Juvenile-Onset Systemic Lupus Erythematosus
    Gawdat, Ghada
    El-Fayoumi, Dina
    Marzouk, Huda
    Farag, Yomna
    SEMINARS IN OPHTHALMOLOGY, 2018, 33 (04) : 470 - 476
  • [24] DISEASE ACTIVITY STATUS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Abdelrahman, N.
    Beresford, M. W.
    Leone, V.
    RHEUMATOLOGY, 2017, 56 : 16 - +
  • [25] Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus
    Hoffman, I. E. A.
    Lauwerys, B. R.
    De Keyser, F.
    Huizinga, T. W. J.
    Isenberg, D.
    Cebecauer, L.
    Dehoorne, J.
    Joos, R.
    Hendrickx, G.
    Houssiau, F.
    Elewaut, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (03) : 412 - 415
  • [26] Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study
    Kisaarslan, Aysenur Pac
    Cicek, Sumeyra Ozdemir
    Batu, Ezgi D.
    Sahin, Sezgin
    Gurgoze, Metin K.
    Cetinkaya, Sibel Balci
    Ekinci, Miray Kisla
    Atmis, Bahriye
    Barut, Kenan
    Adrovic, Amra
    Agar, Buket Esen
    Sahin, Nihal
    Demir, Ferhat
    Baglan, Esra
    Kara, Mehtap Akbalik
    Selcuk, Senay Zirhli
    Ozdel, Semanur
    Comak, Elif
    Akkoyunlu, Betul
    Yener, Gulcin Otar
    Yildirim, Deniz Gezgin
    Ozturk, Kubra
    Yildiz, Mehmet
    Haslak, Fatih
    Sener, Seher
    Kisaoglu, Hakan
    Baba, Ozge
    Kizildag, Zehra
    Isguder, Rana
    Caglayan, Sengul
    Bilgin, Raziye B. Guven
    Aytac, Guelcin
    Yucel, Burcu Bozkaya
    Tanatar, Ayse
    Sonmez, Hafize E.
    Cakan, Mustafa
    Kara, Aslihan
    Elmas, Ahmet T.
    Kilic, Beltinge Demircioglu
    Ayaz, Nuray Aktay
    Kasap, Belde
    Acar, Banu Celikel
    Ozkaya, Ozan
    Yuksel, Selcuk
    Bakkaloglu, Sevcan
    Aydog, Ozlem
    Aksu, Guzide
    Akman, Sema
    Donmez, Osman
    Bulbul, Mehmet
    JOINT BONE SPINE, 2023, 90 (04)
  • [27] Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature
    Chiewchengchol, Direkrit
    Murphy, Ruth
    Edwards, Steven W.
    Beresford, Michael W.
    PEDIATRIC RHEUMATOLOGY, 2015, 13
  • [28] Ventricle disfunction in juvenile-onset systemic lupus erythematosus with renal involvement
    Sampaio, L.
    Moura, C.
    Costa, P.
    Pinto, H.
    Afonso, C.
    Brito, I.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1712 - 1713
  • [29] RENAL BIOMARKERS IN A COHORT OF CHILDREN WITH JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Watson, Louise
    Midgley, A.
    Hanna, L.
    Jones, C.
    Holt, R.
    Pilkington, C.
    Tullus, K.
    Beresford, M. W.
    RHEUMATOLOGY, 2011, 50 : i9 - i9
  • [30] Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jS']jSLE)
    Natoli, Valentina
    Charras, Amandine
    Hahn, Gabriele
    Hedrich, Christian M.
    MOLECULAR AND CELLULAR PEDIATRICS, 2023, 10 (01)